Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Human Metabolome Technologies Hires VP, Business and Product Development

Published: Saturday, June 07, 2014
Last Updated: Wednesday, June 11, 2014
Bookmark and Share
Dr. Alexander Buko has joined the executive team in a newly created position as Vice President of HMT America reporting to President Tsutotmu Hoshiba.

“I am excited that Alex will be joining our team,” said Hoshiba. “Dr. Buko brings with him over 30 years of pharmaceutical experience with the FDA, Abbott Labs, and most recently with Biogen Idec where he held the position of Senior Director of Translational Medicine. Alex has successfully led large scale omics projects in neurology, immunology and oncology. With extensive experience in protein and metabolite based profiling, Alex will lead project management and develop HMT’s biomarker based platforms.” “I am very honored to join HMT and look forward to working with the research teams in both academia and pharmaceutical companies to further enrich metabolic research,” said Buko. “HMT’s commitment to delivering quantitative and metabolic profiling will set the standard for discovery research to come.”

HMT is also pleased to announce F-SCOPE, a new C13 metabolite profiling platform. “F-SCOPE is the only quantitative C13 profiling assay commercially available,” says Dr. Laura Shelton, the Scientific Project Coordinator. “This assay allows for the quantitative detection of over 55 labeled metabolites involved in central energy metabolism including glycolysis, the TCA cycle, amino acids, purines, and glutathione, reporting C13 and C12 fractions for full flux and pathway based analyses.” “F-SCOPE is ideal for analyzing biochemical networks and metabolic perturbations,” says Dr. Buko. “The addition of F-SCOPE to CARCINOSCOPETM and other HMT services will provide another cutting edge quantitative research tool. The capability to deliver unique quantitative and comparative metabolomics profiles is the hallmark of HMT.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Treatment for Pancreatic Cancer
Researchers at Purdue University have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
How Different People Respond To Aspirin
Study findings could be used to help identify those who would benefit most from aspirin use.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
A Metabolic Twist that Drives Cancer Survival
A novel metabolic pathway that helps cancer cells thrive in conditions that are lethal to normal cells has been identified.
Liver-On-Chip Tracks Dynamics of Cellular Function
Hebrew University’s liver-on-chip platform is uniquely able to monitor metabolic changes indicating mitochondrial damage occurring at drug concentrations previously regarded as safe.
Living Off the Fat of the Land
Do cancer cells synthesize the parts for new cells or scavenge them from the environment?
Liver Disease, Obesity Linked
Kanazawa University researchers find similarities in the impeded signalling between central insulin activity and glucose production in the liver for both obese mice and mice that have had the vagus nerve removed.
Decoding Ties Between Vascular Disease, Alzheimer’s
NIH consortium uses big data, team science to uncover complex interplay of factors.
Gene Identified that May Worsen Cancer Outcome
Some patients with breast cancer, lung cancer and leukaemia seem to fare poorly after treatment because of the effects of a particular gene, a new study finds.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!